HistoScanning<sup>TM</sup> vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methods

Introduction. Prostate cancer (PCa) is one of the most common malignant diseases. The prostate biopsy is the verification standard of PCa. The multifocal biopsy under ultrasound (US) guidance shows high rate of false negative results. As a result, the new diagnostic methods have been discovered. His...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Kotov, R. I. Guspanov, S. A. Pulbere, A. G. Yusufov, A. L. Khachatryan, I. S. Badretdinov, M. S. Zhilov, E. M.  Alekberov, S. L. Logvinova
Format: Article
Language:Russian
Published: Ministry of Health of Russian Federation, Rostov State Medical University, State Budget Educational Institute of Higher Professional Education 2023-12-01
Series:Вестник урологии
Subjects:
Online Access:https://www.urovest.ru/jour/article/view/797
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250118714261504
author S. V. Kotov
R. I. Guspanov
S. A. Pulbere
A. G. Yusufov
A. L. Khachatryan
I. S. Badretdinov
M. S. Zhilov
E. M.  Alekberov
S. L. Logvinova
author_facet S. V. Kotov
R. I. Guspanov
S. A. Pulbere
A. G. Yusufov
A. L. Khachatryan
I. S. Badretdinov
M. S. Zhilov
E. M.  Alekberov
S. L. Logvinova
author_sort S. V. Kotov
collection DOAJ
description Introduction. Prostate cancer (PCa) is one of the most common malignant diseases. The prostate biopsy is the verification standard of PCa. The multifocal biopsy under ultrasound (US) guidance shows high rate of false negative results. As a result, the new diagnostic methods have been discovered. HistoscanningTM is the new method of visualization. HistoscanningTM is a new prostate tissue differentiation technology based on US backscatter analysis. The software analyses tissue density builds a 3D model of the prostate and indicates the localisation of PCa-suspect foci that are targeted for biopsy.Objective. To rate the diagnostic accuracy of HistoscanningTM and identify the benefits of targeted prostate biopsy compared to the multifocal biopsy.Matherials &amp; methods. A prospective study conducted between Jan 2017 and May 2021 is presented. Ninety-hundred nine patients who underwent transrectal prostate biopsy in Pirogov City Clinical Hospital No. 1 were included. Control group A — 443 men after standard multifocal biopsy, comparison group B — 506 men after combined standard multifocal biopsy together with targeted biopsy using HistoscanningTM.Results. In the control group, prostate cancer was detected in 33.4% of patients, while in the group using the HistoscanningTM device it was found in 39.7%. ISUP 1 high-grade PCa were more frequent in group В — 71.1%, in group А— 52.7%. Isolated lesion of targeted biopsy specimens was found only in 9 patients (4.5%) of the group В. Combined lesion of standard and targeted biopsy specimens was more frequent and was detected in 121 patients. However, in 72 patients no atypical cells were detected in targeted biopsy specimens when prostate cancer was verified in standard biopsy specimens. The efficacy of HistoscanningTM was comparable to standard biopsy for prostate volumes &gt; 60 cс.Conclusion. The use of HistoscanningTM improves the diagnosis of PCa, mainly due to the ISUP 1. Performing only targeted cores is impractical due to the high percentage of false negative results. Combined prostate biopsy with mandatory sampling of targeted biopsy cores along with standard biopsy specimens is indicated. The diagnostic accuracy of HistoscanningTM showed the best results with a prostate volume &lt;60 cc.
format Article
id doaj-art-eaaf42fba2fb47d3828c642b0b0e5dfa
institution Kabale University
issn 2308-6424
language Russian
publishDate 2023-12-01
publisher Ministry of Health of Russian Federation, Rostov State Medical University, State Budget Educational Institute of Higher Professional Education
record_format Article
series Вестник урологии
spelling doaj-art-eaaf42fba2fb47d3828c642b0b0e5dfa2025-08-20T03:57:21ZrusMinistry of Health of Russian Federation, Rostov State Medical University, State Budget Educational Institute of Higher Professional EducationВестник урологии2308-64242023-12-01114627110.21886/2308-6424-2023-11-4-62-71489HistoScanning<sup>TM</sup> vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methodsS. V. Kotov0R. I. Guspanov1S. A. Pulbere2A. G. Yusufov3A. L. Khachatryan4I. S. Badretdinov5M. S. Zhilov6E. M.  Alekberov7S. L. Logvinova8Pirogov Russian National Research Medical University; Pirogov City Clinical Hospital No. 1; "Kommunarka" Moscow Multidisciplinary Clinical CentrePirogov Russian National Research Medical University; Pirogov City Clinical Hospital No. 1; "Kommunarka" Moscow Multidisciplinary Clinical CentrePirogov Russian National Research Medical UniversityPirogov Russian National Research Medical University; "Kommunarka" Moscow Multidisciplinary Clinical CentrePirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityIntroduction. Prostate cancer (PCa) is one of the most common malignant diseases. The prostate biopsy is the verification standard of PCa. The multifocal biopsy under ultrasound (US) guidance shows high rate of false negative results. As a result, the new diagnostic methods have been discovered. HistoscanningTM is the new method of visualization. HistoscanningTM is a new prostate tissue differentiation technology based on US backscatter analysis. The software analyses tissue density builds a 3D model of the prostate and indicates the localisation of PCa-suspect foci that are targeted for biopsy.Objective. To rate the diagnostic accuracy of HistoscanningTM and identify the benefits of targeted prostate biopsy compared to the multifocal biopsy.Matherials &amp; methods. A prospective study conducted between Jan 2017 and May 2021 is presented. Ninety-hundred nine patients who underwent transrectal prostate biopsy in Pirogov City Clinical Hospital No. 1 were included. Control group A — 443 men after standard multifocal biopsy, comparison group B — 506 men after combined standard multifocal biopsy together with targeted biopsy using HistoscanningTM.Results. In the control group, prostate cancer was detected in 33.4% of patients, while in the group using the HistoscanningTM device it was found in 39.7%. ISUP 1 high-grade PCa were more frequent in group В — 71.1%, in group А— 52.7%. Isolated lesion of targeted biopsy specimens was found only in 9 patients (4.5%) of the group В. Combined lesion of standard and targeted biopsy specimens was more frequent and was detected in 121 patients. However, in 72 patients no atypical cells were detected in targeted biopsy specimens when prostate cancer was verified in standard biopsy specimens. The efficacy of HistoscanningTM was comparable to standard biopsy for prostate volumes &gt; 60 cс.Conclusion. The use of HistoscanningTM improves the diagnosis of PCa, mainly due to the ISUP 1. Performing only targeted cores is impractical due to the high percentage of false negative results. Combined prostate biopsy with mandatory sampling of targeted biopsy cores along with standard biopsy specimens is indicated. The diagnostic accuracy of HistoscanningTM showed the best results with a prostate volume &lt;60 cc.https://www.urovest.ru/jour/article/view/797prostate biopsyhistoscanningprostate cancertargeted biopsies
spellingShingle S. V. Kotov
R. I. Guspanov
S. A. Pulbere
A. G. Yusufov
A. L. Khachatryan
I. S. Badretdinov
M. S. Zhilov
E. M.  Alekberov
S. L. Logvinova
HistoScanning<sup>TM</sup> vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methods
Вестник урологии
prostate biopsy
histoscanning
prostate cancer
targeted biopsies
title HistoScanning<sup>TM</sup> vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methods
title_full HistoScanning<sup>TM</sup> vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methods
title_fullStr HistoScanning<sup>TM</sup> vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methods
title_full_unstemmed HistoScanning<sup>TM</sup> vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methods
title_short HistoScanning<sup>TM</sup> vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methods
title_sort histoscanning sup tm sup vs standard multifocal biopsy for prostate cancer diagnosis a comparison of diagnostic methods
topic prostate biopsy
histoscanning
prostate cancer
targeted biopsies
url https://www.urovest.ru/jour/article/view/797
work_keys_str_mv AT svkotov histoscanningsuptmsupvsstandardmultifocalbiopsyforprostatecancerdiagnosisacomparisonofdiagnosticmethods
AT riguspanov histoscanningsuptmsupvsstandardmultifocalbiopsyforprostatecancerdiagnosisacomparisonofdiagnosticmethods
AT sapulbere histoscanningsuptmsupvsstandardmultifocalbiopsyforprostatecancerdiagnosisacomparisonofdiagnosticmethods
AT agyusufov histoscanningsuptmsupvsstandardmultifocalbiopsyforprostatecancerdiagnosisacomparisonofdiagnosticmethods
AT alkhachatryan histoscanningsuptmsupvsstandardmultifocalbiopsyforprostatecancerdiagnosisacomparisonofdiagnosticmethods
AT isbadretdinov histoscanningsuptmsupvsstandardmultifocalbiopsyforprostatecancerdiagnosisacomparisonofdiagnosticmethods
AT mszhilov histoscanningsuptmsupvsstandardmultifocalbiopsyforprostatecancerdiagnosisacomparisonofdiagnosticmethods
AT emalekberov histoscanningsuptmsupvsstandardmultifocalbiopsyforprostatecancerdiagnosisacomparisonofdiagnosticmethods
AT sllogvinova histoscanningsuptmsupvsstandardmultifocalbiopsyforprostatecancerdiagnosisacomparisonofdiagnosticmethods